Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.
Autor: | Ades, L. *, Mohamed, H. *, Vassilief, D. *, Berger, E. *, Slama, B. *, Vey, N. *, Delarue, R. *, Beyne-Rauzy, O. *, Guerci, A. *, Cheze, S. *, Thomas, X., Stamatoullas, A. *, Gardembas, M. *, Bauduer, F. *, Kolb, A. *, Chaury, M.C. *, Legros, L. *, Damaj, G. *, Hamza, F. *, Vaultier, S. *, Dreyfus, F., Fenaux, P. |
---|---|
Zdroj: | In Blood 16 November 2005 106(11):2537-2537 |
Databáze: | ScienceDirect |
Externí odkaz: |